Loading...

Pfizer to invest USD350 mn in China biotech hub

Image

28-Jun-16 Pfizer Inc will invest USD350 mn to build a biotech center in China, the latest in move by pharma industry giants to set up in the world's no.2 drugs market, with the aim of securing faster approvals for products. The facility in Hangzhou - Pfizer's first biotech center in Asia - is expected to be completed by 2018. [image: Reuters / Andrew Kelly]

Read More

Chinese-owned Bricon acquires renowned German medical device company

Image

15-Jun-16 Bricon GmbH, part of China's Naton Medical Group, has acquired the manufacturing site of Zrinski AG in Germany and has re-formed it as Zrinski GmbH. Naton, with more than 3,500 employees, is one of China’s leading medical technology manufacturers. It intends to expand its position in the premium segment of the Chinese market with products “Made in Germany”. [image: Zrinski]

Read More

Fullerton Health in proposed Singapore listing

Image

11-May-16 In what could be one of Singapore's biggest IPOs in more than a year, managed healthcare provider Fullerton Health is said to be seeking to raise some SGD300 mn. The group - which owns 200 clinics and facilities - is understood to have a capitalisation of SGD1.5 bn, making it the third largest healthcare outfit after IHH and Raffles. [image: Bloomberg]

Read More

Panasonic Healthcare Indonesia upbeat over exports

Image

19-May-16 Panasonic Healthcare Indonesia, a Panasonic subsidiary producing medical equipment, plans to increase sales by 70% over the next four years on the back of growing exports. The company eyes USD88 mn in sales by 2020, up from USD51 mn in 2015. Panasonic acquired Bayer Diabetes Care earlier this year, opening up opportunities for the Indonesian unit to tap offshore markets. [image: Jakarta Globe]

Read More

China's private hospitals - set for growth

Image

 Articles

Changing demographics and lifestyles in China are the reasons behind emerging opportunities for foreign companies to operate hospitals, clinics and care homes in the country. The range of incentives for foreign investors is increasingly wide, but there remain hurdles to be overcome. [image: Asian Hospital & Healthcare Management]

Read More
Share